CONGRATULATION ON FIRST PATIENT RANDOMIZED IN ASIA-PACIFIC (APAC) [MOR202C206]

Congratulations Associate Prof. Dr. Ng Kok Peng and the study team on the First Patient Randomized in Asia-Pacific (APAC) (Second Patient Randomized Globally) for the MOR202C206 study!!
Your hard work and effort are deeply meaningful to UMMC and the nation.

Details of the study: https://clinicaltrials.gov/ct2/show/NCT05065970

Anti-CD38Antibody, BeAHero, CICUMMC, ClinicalInvestigationCentre, ClinicalResearch,

ClinicalResearchinMalaysia, ClinicalTrials, Felzartamab, IgANephropathy, KidneyDisease,

LeaderinClinicalResearch, Malaysia, MOR202C206, Recruiting

 

Share:

More Posts

MERRY CHRISTMAS & HAPPY NEW YEAR

Wishing you wonderful Merry Christmas & a Happy New Year 2024! #BeAHero#CIC#UMMC#LeaderinClinicalResearch#ClinicalResearchinMalaysia#ClinicalInvestigationCentre#MedicalDevice#Phase1#phaseoneB

SELAMAT MENYAMBUT HARI DEEPAVALI 2023

Pulau pandan jauh ke tengahGunung daik bercabang tigaDeepavali disambut megahWujudkan kemuafakatan kita bersama Selamat Menyambut Hari Deepavali Kepada Semua Staf Pusat Perubatan Universiti Malaya daripada

Newsletter

Scroll to Top